ORIC Pharmaceuticals Ownership | Who Owns ORIC Pharmaceuticals?
ORIC Pharmaceuticals Ownership Summary
ORIC Pharmaceuticals is owned by 98.99% institutional investors, 9.13% insiders. Nextech invest is the largest institutional shareholder, holding 7.85% of ORIC shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.67% of its assets in ORIC Pharmaceuticals shares.
ORIC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ORIC Pharmaceuticals | 98.99% | 9.13% | -8.12% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nextech invest | 5.29M | 7.85% | $37.37M |
| Fmr | 4.92M | 7.31% | $34.79M |
| Blackrock | 4.83M | 7.17% | $34.15M |
| Vr adviser | 4.39M | 6.53% | $31.07M |
| Frazier life sciences management | 4.14M | 6.15% | $29.29M |
| Viking global investors lp | 4.00M | 5.94% | $28.28M |
| Alkeon capital management | 3.80M | 5.65% | $26.89M |
| Column group | 3.54M | 5.26% | $25.03M |
| Ecor1 capital | 3.42M | 5.08% | $24.17M |
| Vanguard group | 3.20M | 4.75% | $22.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Column group | 3.54M | 35.12% | $25.03M |
| Invus financial advisors | 1.01M | 7.98% | $7.12M |
| Nextech invest | 5.29M | 6.29% | $37.37M |
| Vr adviser | 4.39M | 1.98% | $31.07M |
| Silverarc capital management | 1.08M | 1.79% | $7.61M |
| First turn management | 1.52M | 1.74% | $10.72M |
| Frazier life sciences management | 4.14M | 1.37% | $29.29M |
| Altium capital management lp | 405.00K | 1.17% | $2.86M |
| Commodore capital lp | 2.00M | 0.97% | $14.14M |
| Euclidean capital | 989.41K | 0.88% | $7.00M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.83M | 0.00% | 1.65M |
| Millennium management | 782.30K | 0.00% | 585.45K |
| State street | 2.26M | 0.00% | 540.15K |
| Vivo capital | 1.27M | 0.83% | 420.00K |
| First turn management | 1.52M | 1.74% | 418.39K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Invesco | 22.62K | - | -471.55K |
| Price t rowe associates inc /md/ | 1.19M | 0.00% | -377.51K |
| Orbimed advisors | - | - | -287.10K |
| Adage capital partners gp | 780.40K | 0.01% | -250.00K |
| Arrowmark colorado | 1.27M | 0.11% | -237.34K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Hennion & walsh asset management | 102.43K | 0.04% | 102.43K | $724.21K |
| Swiss national bank | 66.30K | 0.00% | 66.30K | $468.74K |
| Ubs asset management americas | 42.32K | 0.00% | 42.32K | $299.20K |
| Corton capital | 36.64K | 0.14% | 36.64K | $259.07K |
| Verition fund management | 34.23K | 0.00% | 34.23K | $241.99K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Nbc securities | -118.00 |
| Federated hermes | -152.00 |
| Advisor group | -281.00 |
| Pacer advisors | -661.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 123 | 10.81% | 69,828,652 | 3.33% | 98 | 0.98% | 62 | -16.22% | 38 | 100.00% |
| Jun 30, 2024 | 111 | -2.63% | 67,581,249 | 5.85% | 100 | 1.12% | 74 | 10.45% | 19 | -32.14% |
| Mar 31, 2024 | 114 | 20.00% | 63,846,117 | 26.08% | 94 | 1.22% | 67 | 17.54% | 28 | 40.00% |
| Dec 31, 2023 | 95 | 4.40% | 50,638,927 | 5.41% | 88 | 1.26% | 57 | 39.02% | 20 | -28.57% |
| Sep 30, 2023 | 91 | 3.41% | 48,041,195 | 5.50% | 83 | 0.84% | 41 | -28.07% | 28 | 47.37% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.88M | 2.67% | 2.82K |
| iShares Russell 2000 ETF | 1.59M | 2.26% | -3.58K |
| Fidelity Growth Compy Commingled Pl S | 1.28M | 1.82% | 6.36K |
| Fidelity Small Cap Growth | 1.28M | 1.82% | -3.35K |
| Fidelity Growth Compy Commingled Pl O | 1.28M | 1.81% | - |
| Fidelity Growth Company Fund | 743.94K | 1.05% | -1.58K |
| SPDR® S&P Biotech ETF | 712.23K | 1.01% | 7.89K |
| Vanguard Institutional Extnd Mkt Idx Tr | 688.22K | 0.98% | -2.59K |
| Fidelity Small Cap Index | 629.94K | 0.89% | -15.25K |
| Franklin Biotechnology Discv A(acc)USD | 590.88K | 0.84% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 16, 2024 | Piscitelli Dominic | Chief Financial Officer | Sell | $73.30K |
| Dec 16, 2024 | Multani Pratik S | Chief Medical Officer | Sell | $73.29K |
| Dec 16, 2024 | Chacko Jacob | PRESIDENT AND CEO | Sell | $204.21K |
| Mar 06, 2024 | Chacko Jacob | PRESIDENT AND CEO | Sell | $648.38K |
| Feb 07, 2024 | Chacko Jacob | PRESIDENT AND CEO | Sell | $320.19K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | 3 |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 3 |
| 2023 Q4 | - | 3 |
| 2023 Q3 | - | 3 |
ORIC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools